{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:32:49Z","timestamp":1791261169993,"version":"4.1.0"},"reference-count":28,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11,1]]},"abstract":"<jats:p>OBJECTIVE. No consensus exists among general pediatricians or pediatric rheumatologists regarding whether corticosteroid therapy ameliorates the acute manifestations of Henoch-Scho\u0308nlein purpura or mitigates renal injury. Therefore, we sought to synthesize the reported experimental and observational data regarding corticosteroid use.<\/jats:p>\n               <jats:p>METHODS. We performed a meta-analysis based on a comprehensive review of the literature in the Medline database (1956 to January 2007) and the Cochrane Controlled Trials Register. On the basis of reported outcomes among patients with Henoch-Scho\u0308nlein purpura who were treated at diagnosis with corticosteroids compared with patients treated with supportive care only, we calculated odds ratios for the resolution of abdominal pain, the need for surgical intervention secondary to severe pain or intussusception, the likelihood of Henoch-Scho\u0308nlein purpura recurrence, and the development of transient or persistent renal disease.<\/jats:p>\n               <jats:p>RESULTS. Of 201 articles retrieved from the initial literature search, 15 were eligible for inclusion. Corticosteroid treatment did not reduce the median time to resolution of abdominal pain but did significantly reduce the mean resolution time and increased the odds of resolution within 24 hours. Early corticosteroid treatment significantly reduced the odds of developing persistent renal disease. In addition, although the results were not statistically significant, the prospective data suggest reduced odds of both surgical intervention and recurrence.<\/jats:p>\n               <jats:p>CONCLUSIONS. Corticosteroids, given early in the course of illness, seem to produce consistent benefits for several major clinically relevant Henoch-Scho\u0308nlein purpura outcomes.<\/jats:p>","DOI":"10.1542\/peds.2007-0667","type":"journal-article","created":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T17:08:45Z","timestamp":1193936925000},"page":"1079-1087","source":"Crossref","is-referenced-by-count":186,"title":["Effects of Corticosteroid on Henoch-Scho\u0308nlein Purpura: A Systematic Review"],"prefix":"10.1542","volume":"120","author":[{"given":"Pamela F.","family":"Weiss","sequence":"first","affiliation":[{"name":"Division of Rheumatology"},{"name":"Pediatric Generalist Research Group, Division of General Pediatrics"},{"name":"Division of Biostatistics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Feinstein","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianqun","family":"Luan","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon M.","family":"Burnham","sequence":"additional","affiliation":[{"name":"Division of Rheumatology"},{"name":"Pediatric Generalist Research Group, Division of General Pediatrics"},{"name":"Division of Biostatistics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Feudtner","sequence":"additional","affiliation":[{"name":"Pediatric Generalist Research Group, Division of General Pediatrics"},{"name":"Division of Biostatistics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania"},{"name":"Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2007,11,1]]},"reference":[{"key":"2022051612030298800_R1","unstructured":"Bowyer S, Roettcher P. Pediatric rheumatology clinic populations in the United States: results of a 3 year survey. Pediatric Rheumatology Database Research Group. J Rheumatol.\u20081996;23:1968\u20131974"},{"key":"2022051612030298800_R2","doi-asserted-by":"crossref","unstructured":"Rostoker G. Scho\u0308nlein-Henoch purpura in children and adults: diagnosis, pathophysiology and management. BioDrugs.\u20082001;15:99\u2013138","DOI":"10.2165\/00063030-200115020-00004"},{"key":"2022051612030298800_R3","doi-asserted-by":"crossref","unstructured":"Kobayashi O, Wada H, Okawa K, Takeyama I. Scho\u0308nlein-Henoch's syndrome in children. Contrib Nephrol.\u20081975;4:48\u201371","DOI":"10.1159\/000399697"},{"key":"2022051612030298800_R4","doi-asserted-by":"crossref","unstructured":"Calvin\u0303o MC, Llorca J, Garci\u0301a-Porru\u0301a C, Ferna\u0301ndez-Iglesias JL, Rodriguez-Ledo P, Gonza\u0301lez-Gay MA. Henoch-Scho\u0308nlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study. Medicine (Baltimore).\u20082001;80:279\u2013290","DOI":"10.1097\/00005792-200109000-00001"},{"key":"2022051612030298800_R5","unstructured":"Levy M, Broyer M, Arsan A, Levy-Bentolila D, Habib R. Anaphylactoid purpura nephritis in childhood: natural history and immunopathology. Adv Nephrol Necker Hosp.\u20081976;6:183\u2013228"},{"key":"2022051612030298800_R6","doi-asserted-by":"crossref","unstructured":"Ronkainen J, Ala-Houhala M, Huttunen NP, et al. Outcome of Henoch-Schoenlein nephritis with nephrotic-range proteinuria. Clin Nephrol.\u20082003;60:80\u201384","DOI":"10.5414\/CNP60080"},{"key":"2022051612030298800_R7","doi-asserted-by":"crossref","unstructured":"Ronkainen J, Nuutinen M, Koskimies O. The adult kidney 24 years after childhood Henoch-Scho\u0308nlein purpura: a retrospective cohort study. Lancet.\u20082002;360:666\u2013670","DOI":"10.1016\/S0140-6736(02)09835-5"},{"key":"2022051612030298800_R8","doi-asserted-by":"crossref","unstructured":"Goldstein AR, White RH, Akuse R, Chantler C. Long-term follow-up of childhood Henoch-Scho\u0308nlein nephritis. Lancet.\u20081992;339:280\u2013282","DOI":"10.1016\/0140-6736(92)91341-5"},{"key":"2022051612030298800_R9","doi-asserted-by":"crossref","unstructured":"Ronkainen J, Koskimies O, Ala-Houhala M, et al. Early prednisone therapy in Henoch-Scho\u0308nlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr.\u20082006;149:241\u2013247","DOI":"10.1016\/j.jpeds.2006.03.024"},{"key":"2022051612030298800_R10","doi-asserted-by":"crossref","unstructured":"Reinehr T, Burk G, Berger T, Doeker B, Andler W. Steroids for prophylaxis of nephropathy in Schnlein Henoch purpura? Follow-up of 171 patients [in German]. Klin Padiatr.\u20082000;212:99\u2013102","DOI":"10.1055\/s-2000-9660"},{"key":"2022051612030298800_R11","doi-asserted-by":"crossref","unstructured":"Huber AM, King J, McLaine P, Klassen T, Pothos M. A randomized, placebo-controlled trial of prednisone in early Henoch Scho\u0308nlein purpura [ISRCTN85109383]. BMC Med.\u20082004;2:7","DOI":"10.1186\/1741-7015-2-7"},{"key":"2022051612030298800_R12","doi-asserted-by":"crossref","unstructured":"Saulsbury FT. Corticosteroid therapy does not prevent nephritis in Henoch-Scho\u0308nlein purpura. Pediatr Nephrol.\u20081993;7:69\u201371","DOI":"10.1007\/BF00861574"},{"key":"2022051612030298800_R13","doi-asserted-by":"crossref","unstructured":"Saulsbury FT. Henoch-Scho\u0308nlein purpura in children: report of 100 patients and review of the literature. Medicine (Baltimore).\u20081999;78:395\u2013409","DOI":"10.1097\/00005792-199911000-00005"},{"key":"2022051612030298800_R14","doi-asserted-by":"crossref","unstructured":"Mollica F, Li Volti S, Garozzo R, Russo G. Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura. Eur J Pediatr.\u20081992;151:140\u2013144","DOI":"10.1007\/BF01958961"},{"key":"2022051612030298800_R15","unstructured":"Buchanec J, Galanda V, Minarik M, Zibolen M. Can the nephropathy in Schonlein-Henoch purpura (syndrome) be prevented by early administration of steroids?Clin Nephrol.\u20081987;28:156"},{"key":"2022051612030298800_R16","doi-asserted-by":"crossref","unstructured":"Temmel AF, Emminger W, Schroth B, Zaunschirm HA, Gadner H. Early prednisone treatment and nephropathy in anaphylactoid purpura. Eur J Pediatr.\u20081993;152:782\u2013783","DOI":"10.1007\/BF01954006"},{"key":"2022051612030298800_R17","doi-asserted-by":"crossref","unstructured":"Dawod ST, Akl KF. Henoch-Scho\u0308enlein syndrome in Qatar: the effects of steroid therapy and paucity of renal involvement. Ann Trop Paediatr.\u20081990;10:279\u2013284","DOI":"10.1080\/02724936.1990.11747443"},{"key":"2022051612030298800_R18","doi-asserted-by":"crossref","unstructured":"Reinehr T, Burk G, Andler W. Does steroid treatment of abdominal pain prevent renal involvement in Henoch-Scho\u0308nlein purpura?J Pediatr Gastroenterol Nutr.\u20082000;31:323\u2013324","DOI":"10.1097\/00005176-200009000-00028"},{"key":"2022051612030298800_R19","doi-asserted-by":"crossref","unstructured":"Rosenblum ND, Winter HS. Steroid effects on the course of abdominal pain in children with Henoch-Schonlein purpura. Pediatrics.\u20081987;79:1018\u20131021","DOI":"10.1542\/peds.79.6.1018"},{"key":"2022051612030298800_R20","unstructured":"Chao HC, Kong MS, Lin SJ. Hepatobiliary involvement of Henoch-Scho\u0308nlein purpura in children. Acta Paediatr Taiwan.\u20082000;41:63\u201368"},{"key":"2022051612030298800_R21","doi-asserted-by":"crossref","unstructured":"Trapani S, Micheli A, Grisolia F, et al. Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum.\u20082005;35:143\u2013153","DOI":"10.1016\/j.semarthrit.2005.08.007"},{"key":"2022051612030298800_R22","doi-asserted-by":"crossref","unstructured":"Buchanec J, Galanda V, Bela\u0301kova\u0301 S, Mina\u0301rik M, Zibolen M. Incidence of renal complications in Scho\u0308nlein-Henoch purpura syndrome in dependence of an early administration of steroids. Int Urol Nephrol.\u20081988;20:409\u2013412","DOI":"10.1007\/BF02549574"},{"key":"2022051612030298800_R23","doi-asserted-by":"crossref","unstructured":"Gonzalez-Gay MA, Llorca J. Controversies on the use of corticosteroid therapy in children with Henoch-Scho\u0308nlein purpura. Semin Arthritis Rheum.\u20082005;35:135\u2013137","DOI":"10.1016\/j.semarthrit.2005.06.004"},{"key":"2022051612030298800_R24","unstructured":"Buchanec J, Galanda V, Belakova S, Minarik M, Zibolen M. The effect of prednisone in the development of nephropathy in Schoenlein-Henoch purpura [in Slovak]. Cesk Pediatr.\u20081989;44:145\u2013146"},{"key":"2022051612030298800_R25","doi-asserted-by":"crossref","unstructured":"Philpott MG, Briggs JN. Treatment of the Schoenlein-Henoch syndrome with adrenocorticotrophic hormone (A.C.T.H.) and cortisone. Arch Dis Child.\u20081953;28:57\u201360","DOI":"10.1136\/adc.28.137.57"},{"key":"2022051612030298800_R26","unstructured":"Newberger J. Surviving the night shift. Emerg Med Serv.\u20082007;36(2):77\u201379"},{"key":"2022051612030298800_R27","doi-asserted-by":"crossref","unstructured":"Wooditch AC, Aronoff SC. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children. Pediatrics.\u20082005;116:989\u2013995","DOI":"10.1542\/peds.2005-0504"},{"key":"2022051612030298800_R28","doi-asserted-by":"crossref","unstructured":"Inoue Y, Okada Y, Shinohara M, et al. A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome. J Pediatr.\u20082006;149:336\u2013341","DOI":"10.1016\/j.jpeds.2006.05.025"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/120\/5\/1079\/1031397\/zpe01107001079.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/120\/5\/1079\/1031397\/zpe01107001079.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T12:03:12Z","timestamp":1652702592000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/120\/5\/1079\/71066\/Effects-of-Corticosteroid-on-Henoch-Scho-nlein"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,1]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2007,11,1]]},"published-print":{"date-parts":[[2007,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2007-0667","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,1]]}}}